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Susac’s syndrome
Stavroula Boukouvala1, Saiju Jacob1, Mark Lane1, Alastair K Denniston1,2* and Michael A Burdon1Abstract
Background: We report an interesting case of asymptomatic retinal involvement in an encephalopathic patient
enabling early identification of Susac’s syndrome.
Case presentation: A 39-year-old Caucasian lady with hearing loss and encephalopathy was referred for ophthalmic
assessment, including screening for branch retinal artery occlusions characteristic of Susac’s syndrome. Clinical features
included severe headaches, right-sided hypoacusis, dysphasia and poor memory. Routine blood tests were normal. MRI
brain showed numerous hyperintense lesions mainly in corpus callosum. Although she was visually asymptomatic,
dilated funduscopy detected bilateral multiple peripheral branch retinal artery occlusions which were confirmed on
fluorescein angiography. She was subsequently started on intravenous steroids and pulsed cyclophosphamide which
improved her symptoms within 48 hours. Full recovery was made with no new arterial occlusions on four months
follow-up.
Conclusion: The case further establishes the crucial role of a detailed ophthalmic examination supported by fluorescein
angiography in the assessment of these patients, who are at risk of being misdiagnosed and undertreated.
Keywords: Susac’s syndrome (SS), Retinopathy, Fluorescein angiographyBackground
Sucas’s syndrome (SS) is a retinocochleocerebral vascu-
lopathy. It is characterized by the typical triad of ence-
phalopathy, retinopathy and sensorineural hearing loss,
which was first described by J.O Susac in 1979 and since
when around 300 cases have been reported [1-3]. The
vast majority of them have been published within the
last two decades which changed the initial perception
about the rare prevalence of the disease.
SS manifests more often in women between their third
and fourth decade [2]. The pathogenesis of this micro-
angiopathy remains questionable. It is likely that auto-
immune dysfunction plays a crucial role as anti-endothelial
cell antibodies have been detected in studies where analysis
of serum sample from patients with SS was made [4,5].
However, further research is required in order to explain
the aetiology behind this autoimmune process which leads
to the damage of peripheral vessels of specific organs in SS.* Correspondence: a.denniston@bham.ac.uk
1University Hospital Birmingham NHS Foundation Trust, Queen Elizabeth
Hospital Birmingham, Mindelsohn Way, Edgbaston, Birmingham B15 2WB, UK
2Centre for Translational Inflammation Research, Division of Immunity and
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distribution, and reproduction in any mediumIt is of interest to note that histological examinations in
specimens from a patient with SS suggest that the cause
of the retinal arterial wall plaque is the accumulation of
serous deposits between the retinal blood vessels and the
internal limiting membrane which leads to compression
or even occlusion of them. In their report McLeod et al.
noted that capillaries with thickened walls and narrow
lumens around the optic nerve head were surrounded by
corpora amylacea formations which they suggested were
likely to be the result of microinfarcts arising from a capil-
lary angiopathy [6].
It has been suggested that retinopathy with branch re-
tinal artery occlusions (BRAO) and hearing loss are not
always essential in order to have the diagnosis of SS as
long as encephalopathy and pathognomonic radiological
findings are present [2]. Multiple sclerosis (MS) or acute
disseminated encephalomyelitis (ADEM) can mimic SS
not only in symptoms but also in MRI changes, which
results in a late diagnosis or even misdiagnosis of
SS. This is unfortunate as SS can often be treated success-
fully, with no recurrence [7].
Careful interpretation of radiographic findings may
establish the correct diagnosis. In SS the corpus callosumntral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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located and with a ‘punched-out’ appearance. Leptomenin-
geal enhancement may also be positive but is not always
present. Lesions in patients with MS and ADEM typically
involve the undersurface of the corpus callosum and lepto-
memingeal involvement is not typical [8].
Due to its underlying immunopathogenesis, SS is being
widely treated with high dose intravenous corticosteroids
plus a second immunosuppressant. Although the rar-
ity of the disease means that there are no randomized
controlled treatment trials, the literature provides re-
ports of cases and case series treated with agents such
as intravenous immunoglobulin, mycophenolate mofetil,
cyclophosphamide, plasma exchange, azathioprine, ritu-
ximab and methotrexate have been used [3,9,10]. Further-
more long-term treatment with Aspirin may be added to
the immunosuppressive treatment in cases where BRAO is
confirmed [11]. Li et al. recommend hyperbaric oxygen to
attempt to reverse visual loss, although this is not generally
practiced [12]. It would appear that early and aggressive
treatment is associated with a steady recovery of symptoms
with an excellent prognosis.
We present here a case of a 39-year-old female who
presented acutely to the neurology team with rapidly
progressive encephalopathy and hearing loss. The possi-
bility of SS was raised following investigation with brain
imaging which showed suggestive corpus callosal lesions.Figure 1 SS findings on MRI brain (A, B), fundus photographs (C) and fu
out lesions in the corpus callosum (arrowed) typical of Susac’s syndrome. B. A
inflammation in the posterior corpus callosum (arrow) C. Colour fundus photo
fundus (OS). D. Fundus fluorescein angiographic image showing the same les
on clinical examination alone (unbroken arrows).A referral to the Ophthalmology department was made
and the diagnosis was confirmed by the presence of
multiple branch retinal artery occlusions.
Case presentation
A 39-year-old Caucasian lady presented with five weeks
of severe vertigo, headaches and rapidly progressive con-
fusion, following a trip to Tunisia. She reported no visual
symptoms. She had a past medical history of bipolar
disorder diagnosed two years previously. Neurological
examination revealed right-sided hypoacusis, dysphasia,
ataxia and poor memory. Haematological and biochemical
profile was normal. Serological screening for infectious
agents was negative. Lumbar puncture revealed marginally
elevated opening pressure, raised protein with no cells and
no oligoclonal bands. A T1-weighted brain MRI revealed
inflammatory changes, with multiple ‘punched-out’ lesions
in the corpus callosum (Figure 1A). On T2- weighted
MRI “snow ball” appearance of inflammation in the
posterior corpus callosum was found (Figure 1B). These
features were identified as being suggestive of SS, and thus
an ophthalmology opinion was sought. On ophthalmic
examination, patient’s best corrected visual acuity was 6/9
in the right and 6/6 in the left eye. There was no afferent
pupillary defect or abnormal colour vision in either eye.
Dilated fundal examination revealed healthy discs and
maculae but multiple BRAO bilaterally (Figure 1C), whichndus angiography (D). A. T1-weighted MRI brain showing punched
xial T2- weighted MRI brain showing typical “snow ball” appearance of
graph showing branch retinal artery occlusion (arrowed) in the peripheral
ion (broken arrow) and additional occlusions not previously recognised
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angiography (Figure 1D). The rest of ophthalmic exami-
nation was otherwise unremarkable. A diagnosis of SS was
made. Treatment with intravenous methylprednisolone
and cyclophosphamide resulted in stabilisation of disease
within the first 48 hours. The patient made a steady reco-
very of function, including mobility, speech, hearing and
memory. On six weeks ophthalmology follow-up she had
an unaided vision of 6/5 bilaterally without new arterial
occlusions. No relapses have been noted after a period of
ten months.Conclusions
The diagnosis of SS is challenging. The classic triad of
SS may not be present at the onset of the disease and
the retinal involvement which is commonly asympto-
matic may be missed.
Although headache is the commonest initial symptom
for any manifestations of encephalopathy, transient per-
sonality and mental changes are also common in SS [13].
Interestingly psychiatric symptoms mimicking bipolar
spectrum disorder have been described in a case of SS in
the past but it was unclear whether they were truly re-
lated to SS as they started three decades after the initial
SS clinical signs [14]. Our patient suffered from bipolar
disorder diagnosed two years previously, but we do not
think that this has any relation to her Susac’s syndrome.
SS-associated retinal artery occlusions are of importance
both because they may cause severe visual loss (depending
on the arteriole involved) but also because they may
hold the key to rapid diagnosis and early initiation of
immunosuppression. In SS, retinal artery occlusions have a
characteristic pattern on fluorescein angiography with ar-
terial wall hyperfluorescence due to atheromatous plaques,
also called “Gass plaques” and are usually distally located
from the bifurcation [15]. Indocyanine green angiography
shows normal choroidal circulation [16]. Optical coher-
ence tomography (OCT) may also be useful in the clinical
challenge of differentiating SS from MS. Brandt et al. have
reported that Susac patients show a more distinct sectorial
pattern of reduction in both macular and retinal nerve fibre
layer thickness in contrast to the more diffuse changes seen
in MS patients [17]. Seven-Tesla MRI may also aid in
further refinement in terms of identifying the charac-
teristic radiological changes observed in SS. In their study
of five patients with SS and ten age and sex-matched pa-
tients with MS, Wuerfel et al. observed that using the
T2-weighted FLASH (Fast Low Angle SHot) sequences,
most (92%) white matter lesions in MS were centred on a
small vein and were often (41%) characterized by a hypo-
intense rim, whereas white matter lesions in SS were less
commonly (54%) surrounding an identifiable vessel and
rarely (4%) exhibited a hypointense rim. The authors alsonoted callosal atrophy and CSF-isointense lesions within
the central part of the corpus callosum [18].
Through this case we want to make physicians more
aware of the possibility of visually asymptomatic patients
with retinal involvement in SS and suggest detailed
fundoscopic and angiographic assessment by a neuro-
ophthalmologist or retinal specialist in cases where neuro-
logical and radiological investigations raise the possibility
of SS.
Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. A copy of the written consent is available for
review by the Editor of this journal.
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